Novel antidepressant zuranolone effective in alleviating depression and anxiety symptoms Post author: Post published:November 20, 2023 Post category:uncategorized The efficacy and safety of zuranolone in treating major depressive disorder (MDD). You Might Also Like One in six people worldwide affected by loneliness, WHO report reveals June 30, 2025 WHO applauds Guinea’s success in eradicating human African trypanosomiasis January 30, 2025 Study shows impact of primary health care in reducing child mortality in Latin America May 16, 2024